The three-judge panel stated that “there is substantial evidence to support the district court’s conclusion that the [Arkansas] Act prohibits medical treatment that conforms with the recognized standard of care. Even international bodies that consider hormone treatment for adolescents to be ‘experimental’ have not banned the care covered by Act 626.”


Click Here To Read The Full Article